The role of multiparametric MRI in active surveillance for low-risk prostate cancer: The ROMAS randomized controlled trial
- 1 July 2021
- journal article
- research article
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 39 (7) , 433.e1-433.e7
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- MRI Displays the Prostatic Cancer Anatomy and Improves the Bundles Management Before Robot-Assisted Radical ProstatectomyJournal of Endourology, 2018
- MRI-Targeted or Standard Biopsy for Prostate-Cancer DiagnosisNew England Journal of Medicine, 2018
- Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part I: Risk Stratification, Shared Decision Making, and Care OptionsJournal of Urology, 2018
- Survival and Complications Following Surgery and Radiation for Localized Prostate Cancer: An International Collaborative ReviewEuropean Urology, 2018
- 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate CancerNew England Journal of Medicine, 2016
- Random biopsy: when, how many and where to take the cores?World Journal of Urology, 2014
- Small Renal Masses Initially Managed Using Active Surveillance: Results From a Retrospective Study With Long-Term Follow-UpClinical Genitourinary Cancer, 2014
- Optimization of Initial Prostate Biopsy in Clinical Practice: Sampling, Labeling and Specimen ProcessingJournal of Urology, 2013
- Active Surveillance for Low-Risk Prostate Cancer Worldwide: The PRIAS StudyEuropean Urology, 2013
- The Impact of Discordance Between Biopsy and Pathological Gleason Scores on Survival After Radical ProstatectomyJournal of Urology, 2009